Financial research is never a simple task. It requires a substantial time commitment to read over a company's recent filings and listen to its investor presentation, as well as to get a feel for the industry and sector as a whole. But, even the most bullish research should be viewed with a cautious eye.

One name to be leery of here is

China Medical

(CMED)

, which currently has 27 million shares outstanding. Based in Beijing, China, the medical device company manufactures and markets products using high-intensity focused ultrasound, or HIFU, for the treatment of solid cancers and benign tumors.

To read more,

visit Stockpickr.com

.

Stockpickr is a wholly owned subsidiary of TheStreet.com.